J. Zhang, “Efficacy of Combined SGLT2 Inhibitor and GLP-1 Receptor Agonist Therapy in Managing Diabetic Nephropathy”, Med. Insights, vol. 2, no. 4, pp. 24–35, Nov. 2025, doi: 10.70088/dndqkd52.